Terms: = Breast cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734
179132 results:
1. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
2. Effect of postpartum depression and role of infant feeding practices on relative weight of child at 1 and 3 years of age.
Shrestha D; K C Bhandari A; Ogawa K; Tanaka H; Miyayama C; Horikawa R; Urayama KY; Morisaki N
BMC Pregnancy Childbirth; 2024 May; 24(1):336. PubMed ID: 38698333
[TBL] [Abstract] [Full Text] [Related]
3. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes.
Ping J; Jia G; Cai Q; Guo X; Tao R; Ambrosone C; Huo D; Ambs S; Barnard ME; Chen Y; Garcia-Closas M; Gu J; Hu JJ; John EM; Li CI; Nathanson K; Nemesure B; Olopade OI; Pal T; Press MF; Sanderson M; Sandler DP; Yoshimatsu T; Adejumo PO; Ahearn T; Brewster AM; Hennis AJM; Makumbi T; Ndom P; O'Brien KM; Olshan AF; Oluwasanu MM; Reid S; Yao S; Butler EN; Huang M; Ntekim A; Li B; Troester MA; Palmer JR; Haiman CA; Long J; Zheng W
Nat Commun; 2024 May; 15(1):3718. PubMed ID: 38697998
[TBL] [Abstract] [Full Text] [Related]
4. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4.
Santiso A; Heinemann A; Kargl J
Pharmacol Rev; 2024 May; 76(3):388-413. PubMed ID: 38697857
[TBL] [Abstract] [Full Text] [Related]
5. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
6. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
van Maaren MC; van Hoeve JC; Korevaar JC; van Hezewijk M; Siemerink EJM; Zeillemaker AM; Klaassen-Dekker A; van Uden DJP; Volders JH; Drossaert CHC; Siesling S;
Support Care Cancer; 2024 May; 32(5):323. PubMed ID: 38695938
[TBL] [Abstract] [Full Text] [Related]
7. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract] [Full Text] [Related]
8. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract] [Full Text] [Related]
9. Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.
van Veghel W; van Dijk SC; Klem TM; Weel AE; Bügel JB; Birnie E
BMJ Open; 2024 May; 14(5):e080257. PubMed ID: 38692726
[TBL] [Abstract] [Full Text] [Related]
10. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With breast cancer.
Shaw JA; Page K; Wren E; de Bruin EC; Kalashnikova E; Hastings R; McEwen R; Zhang E; Wadsley M; Acheampong E; Renner D; Gleason KLT; Ambasager B; Stetson D; Fernandez-Garcia D; Guttery D; Allsopp RC; Rodriguez A; Zimmermann B; Sethi H; Aleshin A; Liu MC; Richards C; Stebbing J; Ali S; Rehman F; Cleator S; Kenny L; Ahmed S; Armstrong AC; Coombes RC
JCO Precis Oncol; 2024 Apr; 8():e2300456. PubMed ID: 38691816
[TBL] [Abstract] [Full Text] [Related]
11. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract] [Full Text] [Related]
12. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
13. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
14. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
[TBL] [Abstract] [Full Text] [Related]
15. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
[TBL] [Abstract] [Full Text] [Related]
16. Multidisciplinary analysis of cancer-related fatigue at the time of diagnosis: preliminary results of the BIOCARE FActory cohort.
Leclercq A; Chatrenet A; Bourgeois H; Cojocarasu O; Mathie C; Martin T; Rahmani A; Morel B
Support Care Cancer; 2024 Apr; 32(5):319. PubMed ID: 38689167
[TBL] [Abstract] [Full Text] [Related]
17. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
18. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
Li Z; Wang Y
J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
[TBL] [Abstract] [Full Text] [Related]
19. Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
Łukasiewicz-Śmietańska D; Godlewski D; Nowakowska E; Szpak A; Chabros E; Juszczyk G; Charzewska J; Rybaczyk-Pathak D
PLoS One; 2024; 19(4):e0300061. PubMed ID: 38687739
[TBL] [Abstract] [Full Text] [Related]
20. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
[Next]
